Balancing Innovation and Practicality in Immuno-Oncology Dose Selection

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/d0/cb/0d/d0cb0de6-ff12-70cd-fba5-6720111b2cf4/mza_5543077143899086824.jpg/600x600bb.jpg

PharmaTalkRadio

Conference Forum

530 episodes

3 weeks ago

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

All content for PharmaTalkRadio is the property of Conference Forum and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Balancing Innovation and Practicality in Immuno-Oncology Dose Selection

PharmaTalkRadio

45 minutes

3 weeks ago

Balancing Innovation and Practicality in Immuno-Oncology Dose Selection

About this podcast:
Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for multi-dose selection, alternative dose-selection strategies with imaging, biomarkers and tumor burden analysis, the higher costs and longer timelines, and financial impacts for early-phase oncology companies.

For more information, go to IO360summit.com.